Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-005933
Filing Date
2012-02-02
Accepted
2012-02-01 18:58:27
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-31390_110q.htm 10-Q 1259315
2 EX-31.1 a11-31390_1ex31d1.htm EX-31.1 20349
3 EX-31.2 a11-31390_1ex31d2.htm EX-31.2 21417
4 EX-32.1 a11-31390_1ex32d1.htm EX-32.1 8294
  Complete submission text file 0001104659-12-005933.txt   4228065

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20111231.xml EX-101.INS 576836
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20111231.xsd EX-101.SCH 13126
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20111231_cal.xml EX-101.CAL 46525
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT arry-20111231_lab.xml EX-101.LAB 248207
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20111231_pre.xml EX-101.PRE 123321
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20111231_def.xml EX-101.DEF 88630
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 12563881
SIC: 2834 Pharmaceutical Preparations